Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
White House announces 25 Cancer Moonshot initiatives, including $240M in ARPA-H funds
White House

White House announces 25 Cancer Moonshot initiatives, including $240M in ARPA-H funds

September 22, 2023
Vol.49 No.35
By Matthew Bin Han Ong
In Brief

Patient groups applaud circuit court ruling that largely stays remedy in Braidwood Management v. Becerra

June 16, 2023
Vol.49 No.24
Drug shortages threaten lives—cancer patients cannot wait
Guest Editorial

Drug shortages threaten lives—cancer patients cannot wait

June 02, 2023
Vol.49 No.22
By Karen E. Knudsen
Clinical Roundup

ACS analysis of cancer mortality by congressional district finds decreased death rate in men and women, persistent racial disparities

May 12, 2023
Vol.49 No.19
Clinical Roundup

ACS report: smoking rates, alcohol use, physical inactivity decreased during pandemic; trends in obesity, cervical cancer screening worsen

May 05, 2023
Vol.49 No.18
In Brief

ACS CAN urges House leadership to refrain from tying debt limit proposal to problematic public health provisions

April 28, 2023
Vol.49 No.17
In Brief

ACS receives $11M donation to provide treatment lodging in San Antonio

April 21, 2023
Vol.49 No.16
Drugs & Targets

ArteraAI and ACS form collaboration to use AI for designing personalized therapy

April 14, 2023
Vol.49 No.15
In Brief

IU Cancer Center receives new and renewed ACS funding for research, education programs

March 31, 2023
Vol.49 No.13
In Brief

ACS receives $4M from Genentech to drive health equity

March 24, 2023
Vol.49 No.12

Posts navigation

Previous1…678…12Next

Trending Stories

  • Charles Rudin named cancer center director at MSK
  • Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • FDA’s acting drug chief, acting vaccines chief, and chief of staff ousted in the wake of Makary departure
  • Marcel van den Brink: Microbiome research is now in “critical phase” where evidence points to therapeutic use
  • NCI’s Letai gets softball questions from Senate appropriators at an otherwise contentious hearing

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account